Purple Biotech annual capital expenditures (capex)
2015
2016
2017
2018
2019
2020
2021
2022
2023
2025
Purple Biotech Capital Expenditures (CapEx) Growth & History (PPBT)
Purple Biotech's capital expenditures (capex) was $3,000 for fiscal 2025.
View full Purple Biotech company overviewPurple Biotech annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3,000 | — | — |
| 2023 | 2023-12-31 | $3,000 | −$23,000 | −88.46% |
| 2022 | 2022-12-31 | $26,000 | −$89,000 | −77.39% |
| 2021 | 2021-12-31 | $115,000 | −$41,000 | −26.28% |
| 2020 | 2020-12-31 | $156,000 | $145,000 | +1318.18% |
| 2019 | 2019-12-31 | $11,000 | −$5,000 | −31.25% |
| 2018 | 2018-12-31 | $16,000 | $3,000 | +23.08% |
| 2017 | 2017-12-31 | $13,000 | $3,000 | +30.00% |
| 2016 | 2016-12-31 | $10,000 | $1,000 | +11.11% |
| 2015 | 2015-12-31 | $9,000 | — | — |
Purple Biotech capital expenditures (capex) trends
Over the last five fiscal years, Purple Biotech's capital expenditures (capex) decreased from $156,000 to $3,000, a change of −$153,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Purple Biotech source filings ↗